GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (FRA:MFJ) » Definitions » EV-to-FCF

Polynovo (FRA:MFJ) EV-to-FCF : -47.11 (As of Jul. 18, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Polynovo EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Polynovo's Enterprise Value is €465.09 Mil. Polynovo's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was €-9.87 Mil. Therefore, Polynovo's EV-to-FCF for today is -47.11.

The historical rank and industry rank for Polynovo's EV-to-FCF or its related term are showing as below:

FRA:MFJ' s EV-to-FCF Range Over the Past 10 Years
Min: -665.63   Med: -115   Max: 2317.17
Current: -47.35

During the past 13 years, the highest EV-to-FCF of Polynovo was 2317.17. The lowest was -665.63. And the median was -115.00.

FRA:MFJ's EV-to-FCF is ranked worse than
100% of 385 companies
in the Medical Devices & Instruments industry
Industry Median: 27.21 vs FRA:MFJ: -47.35

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-07-18), Polynovo's stock price is €0.665. Polynovo's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was €0.005. Therefore, Polynovo's PE Ratio (TTM) for today is 133.00.


Polynovo EV-to-FCF Historical Data

The historical data trend for Polynovo's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polynovo EV-to-FCF Chart

Polynovo Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -180.45 -488.97 -353.64 -127.20 2,112.59

Polynovo Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -127.20 - 2,112.59 -

Competitive Comparison of Polynovo's EV-to-FCF

For the Medical Devices subindustry, Polynovo's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polynovo's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polynovo's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Polynovo's EV-to-FCF falls into.


;
;

Polynovo EV-to-FCF Calculation

Polynovo's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=465.087/-9.873
=-47.11

Polynovo's current Enterprise Value is €465.09 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Polynovo's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was €-9.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polynovo  (FRA:MFJ) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Polynovo's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.665/0.005
=133.00

Polynovo's share price for today is €0.665.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Polynovo's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was €0.005.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Polynovo EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Polynovo's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Polynovo Business Description

Traded in Other Exchanges
Address
320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207
Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.

Polynovo Headlines

No Headlines